Sema4’s Acquisition of GeneDx

Fenwick & West advised Sema4 on the deal. Sema4 (Nasdaq: SMFR), an AI-driven genomic and clinical data intelligence platform company, announced its agreement to acquire GeneDx, an...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Velo3D’s Public Listing on NYSE

Fenwick & West advised Velo3D on the deal. Velo3D Inc., a leading additive manufacturing technology company for high-value metal parts, announced its public listing on the New...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here